Abstract:One major pathological hallmark of Alzheimer's disease (AD) is formation of senile plaques, whose major components are small peptides called beta-amyloid (Abeta) that are derived from beta-amyloid precursor protein (APP) through sequential cleavages by beta-secretase (BACE1) and gamma-secretase complex. APP, BACE1 and gamma-secretase complex components are transported through the secretory pathway; and Abeta can be generated at various sub cellular compartments depending on the interaction between APP and BACE1/gamma-secretase. Therefore, dysregulated trafficking of these proteins will affect Abeta generation and contribute to disease pathogenesis. Sorting nexin (SNX) family proteins are a diverse group of cellular trafficking factors that are unified by the presence of a phospholipid-binding motif - the PX domain. The ability of these proteins to bind specific phospholipids, as well as their propensity to form protein-protein complexes, points to a role for these proteins in membrane trafficking and protein sorting. However, information on regulation of AD proteins by SNX members is limited. We modulated the levels of different SNX family members in cell cultures and studied their effects on intracellular trafficking of APP, BACE1, and gamma-secretase components. In addition, we studied whether SNX family members affect APP processing/Abeta generation and the activities of BACE1 and gamma-secretase. Furthermore, we investigated the levels of SNX family members in the brain of patients with AD or other neurodegenerative diseases. We found that some SNX family members can regulate intracellular trafficking of BACE1 and gamma-secretase and thus affect APP processing for Abeta generation. Moreover, we found that the levels of certain SNX family members were altered in the brain of neurodegenerative disease patients when compared to control samples. Our results suggest that certain SNX members regulate intracellular trafficking of BACE1 and gamma-secretase and participate in the pathogenesis of AD and other neurodegenerative diseases.

Sorting Nexin 27 Regulates Aβ Production Through Modulating Γ-Secretase Activity

Down‐regulated Expression of Microrna‐338‐5p Contributes to Neuropathology in Alzheimer's Disease

A Novel Mechanism Underlying Pathogenesis of Down Syndrome

Loss of Sorting Nexin 27 Contributes to Excitatory Synaptic Dysfunction by Modulating Glutamate Receptor Recycling in Down's Syndrome

SNX15 Regulates Cell Surface Recycling of APP and Aβ Generation

Sorting Nexin 12 Interacts with BACE1 and Regulates BACE1-mediated APP Processing

Roles of SNX Family Members in Neurodegenerative Diseases

SNX12 Affects Aβ Generation Through Regulating Subcellular Localization of BACE1

Amyloid-β Precursor Protein Facilitates the Regulator of Calcineurin 1-Mediated Apoptosis by Downregulating Proteasome Subunit Α Type-5 and Proteasome Subunit Β Type-7.

SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse

γ‐Secretase Modulator BPN15606 Reduced Aβ42 and Aβ40 and Countered Alzheimer‐Related Pathologies in a Mouse Model of Down Syndrome

Amyloid Precursor Protein-Mediated Endocytic Pathway Disruption Induces Axonal Dysfunction and Neurodegeneration.

Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose

Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome.

The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases

Overexpression of Human SNX27 Enhances Learning and Memory Through Modulating Synaptic Plasticity in Mice

GSAP Regulates Lipid Homeostasis and Mitochondrial Function Associated with Alzheimer’s Disease

P4-064 Increased BACE1 Maturation in Down Syndrome

Interaction Between Amyloid Precursor Protein and Nogo Receptors Regulates Amyloid Deposition

USP25 inhibition ameliorates Alzheimer’s pathology through the regulation of APP processing and Aβ generation

The Downregulation of ITGAX Exacerbates Amyloid-β Plaque Deposition in Alzheimer's Disease by Increasing Polarization of M1 Microglia